The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.30
Bid: 3.20
Ask: 3.40
Change: 0.05 (1.54%)
Spread: 0.20 (6.25%)
Open: 3.25
High: 3.30
Low: 3.10
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

Thu, 30th Jun 2022 17:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Catalyst Media Group PLC - London-based investment firm - Updates on litigation matter of Sports Information Services Holdings Ltd, in which it holds a 21% stake. SIS's subsidiary has settled matters amicably in the legal dispute with Racing Partnership Ltd. SIS pretax profit for year ended March 31 is between GBP6 million to GBP8 million, swung from a loss year-on-year of GBP7.8 million. "This range reflects certain accruals and provisions relating to costs and settlement of the abovementioned litigation such that no further charges to profit are anticipated. CMG further understands that, following the settlement, SIS continues to hold substantial cash reserves and remains in a strong financial position," CMG explains.

----------

MyHealthChecked PLC - Cardiff-based healthcare company - Ahead of Thursday's annual general meeting, the company says momentum from the recently-announced "record" year of revenue has continued into the new financial year. Says trading in the first half has been stronger than expected, and ahead of budget. Will update further in mid-July.

----------

Ashtead Technology Holdings PLC - Aberdeenshire-based subsea equipment rental firm - Reports "excellent" start to the year, with revenue for the first half expected to grow at least 25% year-on-year to at least GBP31 million. Earnings before interest, tax, depreciation and amortisation margin is expected to be higher than the previous year and in line with expectations. "The business is well placed to continue benefitting from current market conditions during the second half of 2022 as we also seek to continue our focus on operational excellence, and further capitalise on the fungibility of our industry-leading rental fleet to support both oil and gas and renewables markets," says Chief Executive Allan Price.

----------

M&C Saatchi PLC - London-based advertising agency - Trades in line with expectations for pretax profit of GBP31 million for 2022. "The business is well placed to continue benefitting from current market conditions during the second half of 2022 as we also seek to continue our focus on operational excellence, and further capitalise on the fungibility of our industry-leading rental fleet to support both oil and gas and renewables markets," M&C says. At the company's annual general meeting, 32% of shareholders voted against reappointing Gareth Davis and Lisa Gordon. "The board notes that a significant proportion of the votes cast against resolutions 5 and 6 were cast by AdvancedAdvT Ltd and Vin Murria, a director of ADV. ADV has made a hostile offer for the company," M&C says.

----------

ValiRx PLC - Nuneaton, England-based drug development company - Plans to raise GBP1.5 million through a discounted placing. The proceeds will be used for working capital to continue development of its assets and to strengthen the balance sheet with a view to potential acquisitions. ValiRx will place 15 million shares at 10.00p a share, a discount of 38% to 16.25p closing share price on Wednesday. Extends exclusivity period for TheoremRx Inc to complete their financing round and execute the sub-license for VAL201 for use in oncology situations.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Says project finance syndicate Tulu Kapi Gold Mines Share Co signs funding umbrella agreement, setting out the role and contribution of each syndicate member. Prepares to develop the project. "Simultaneous with the triggering of full development at Tulu Kapi, we intend to re-commence exploration programs in Ethiopia and expand our exploration program in Saudi Arabia. In Ethiopia, the initial focus will be underneath the planned open pit where we already have established an initial resource for underground mining at an average grade of 5.7 grams per tonne gold," says Executive Chair Harry Anagnostaras-Adams.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

Read more
6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

Read more
1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

Read more
16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

Read more
8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

ValiRx Delays Annual Results Amid Covid-19 Pandemic

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

Read more
29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

Read more
29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

Read more
27 May 2020 14:20

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

Read more
7 May 2020 14:45

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

Read more
4 May 2020 16:18

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.